Alta Partners

Cambridge fat-burning drug maker Zafgen nabs USD45 million in Series E funding

Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.

Read Full Article

aTyr Pharma collects nearly US$60 million in its latest funding round

aTyr Pharma reveals that it had secured up to US$59 million in financing from current investors and an anonymous global public investment fund.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics